Nevro Corp (NVRO)
3.97
+0.20
(+5.30%)
USD |
NYSE |
Dec 24, 16:00
Nevro Cash from Investing (Quarterly): -6.435M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -102.97M |
| Inari Medical Inc | -34.25M |
| Stereotaxis Inc | 0.098M |
| Electromed Inc | -0.058M |
| Myomo Inc | 2.825M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.732M |
| Cash from Financing (Quarterly) | -0.354M |
| Free Cash Flow | -56.61M |
| Free Cash Flow Per Share (Quarterly) | 0.0043 |
| Free Cash Flow to Equity (Quarterly) | -3.71M |
| Free Cash Flow to Firm (Quarterly) | 4.013M |
| Free Cash Flow Yield | -38.80% |